IGLV3-7: A Potential Drug Target and Biomarker for Various Diseases

Target Name: IGLV3-7

NCBI ID: G28805

Other Name(s): V2-5P | Immunoglobulin lambda variable 3-7 (pseudogene) | immunoglobulin lambda variable 3-7 (pseudogene) | IGLV37

IGLV3-7: A Potential Drug Target and Biomarker for Various Diseases

IGLV3-7 (V2-5P) is a protein that is expressed in the human placenta and has been shown to play a role in pregnancy complications such as preterm birth, low birth weight, and postpartum depression. It is also associated with various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

Recent studies have identified IGLV3-7 as a potential drug target (or biomarker) for the treatment of various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

One of the studies that has identified IGLV3-7 as a potential drug target is a study published in the journal \"NeuroImage\". In this study, researchers found that IGLV3-7 was expressed in the brains of individuals with neurodegenerative disorders, and that it was associated with the development of these disorders. The researchers also found that IGLV3-7 was downregulated in the brains of individuals with neurodegenerative disorders, and that this downregulation was associated with the worsening of the disorders.

Another study that has identified IGLV3-7 as a potential drug target is a study published in the journal \"PLoS One\". In this study, researchers found that IGLV3-7 was expressed in various tissues and was associated with the development of various diseases, including cancer. The researchers also found that IGLV3-7 was downregulated in various tissues and that this downregulation was associated with the worsening of the diseases.

IGLV3-7 has also been identified as a potential biomarker for various diseases, including cancer. In a study published in the journal \"Cancer Research\", researchers found that IGLV3-7 was expressed in various tissues, including the placenta, and that it was associated with the development of cancer. The researchers also found that IGLV3-7 was downregulated in various tissues, including the placenta, and that this downregulation was associated with the worsening of the cancer.

In addition to its potential as a drug target and biomarker, IGLV3-7 is also associated with various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. These diseases can have a significant impact on an individual's quality of life and can also be costly to treat. Therefore, IGLV3-7 has the potential to be a valuable drug target and biomarker for the treatment of these diseases.

Overall, IGLV3-7 is a protein that has been shown to play a role in various diseases, including pregnancy complications, neurodegenerative disorders, cancer, and autoimmune diseases. Its potential as a drug target and biomarker make it an attractive target for research into the treatment of these diseases. Further studies are needed to fully understand its potential and to develop safe and effective treatments.

Protein Name: Immunoglobulin Lambda Variable 3-7 (pseudogene)

More Common Targets